Detailed Narrative
Robust Revenue Growth Driven by PVC Segment
Platinum Industries reported a strong Q3 FY26 standalone revenue of ₹102.62 crores, marking a robust 31% year-over-year growth. This expansion was primarily driven by the growing demand for products in the PVC pipe and fittings segment, benefiting from India's infrastructure boom. For the nine months ended December 31, 2025, the standalone top line reached ₹302.38 crores, up 25% from the previous year, indicating sustained growth momentum.
Margin Moderation and Product Mix Dynamics
Gross margins for Q3 FY26 stood at approximately 31%, a moderation from 32.6% in the prior period. This was attributed to a higher proportion of CPVC sales, which currently have a lower margin compared to other products. Management noted that CPVC contribution margins have improved from 7% last year to ~17% in Q3 FY26, as the company works on raw material alternatives to enhance cost-effectiveness. Overall PAT for the nine-month period was ₹37.58 crores, impacted by higher depreciation from ongoing capacity expansion and lower other income.
Strategic Capacity Expansion and International Foray
The company is actively pursuing significant capacity expansions. The CPVC phase at the Palghar facility is already operational, running at 60-65% of its 12,000 tonnes capacity, with commercial production for Calcium Zinc expected from April. The Egypt plant, a key international expansion, is projected to complete construction by May, begin pre-commissioning by June, and commence commercial production by September 2026, with a final outlook for 100% plant running by December 2026. This facility is expected to unlock high-growth international markets and add cost-efficient capacity.
Diversification into Pharma and Oleo Chemicals
Platinum Industries is strategically diversifying its business. A new subsidiary, Rivadu LifeSciences Pvt Ltd (70% owned by Platinum), has been registered to enter the Pharma sector, focusing on nutraceuticals, APIs, excipients, and niche products, with revenue generation expected from FY27. Additionally, the company is investing in Platinum Oleo Chemicals, which develops derivatives for the polyolefin sector. A Capex of ₹150-200 crores is planned for next year to establish a 40,000-tonne capacity for Oleamides and derivatives, currently operating on a CDMO model.
Ambitious Growth Targets and Margin Outlook
Management has set ambitious growth targets, aiming for over 40% revenue growth in FY27 and a 35% CAGR from FY26 to FY29. The revenue potential from Indian factories (PVC and CPVC) is estimated at ₹1,300-1,350 crores over 3-4 years, while the Egypt plant is targeted to generate ₹250-300 crores over three years. The Egypt facility is also expected to yield higher contribution margins for lead products (23-24% vs. 18-19% in India) and an initial EBITDA margin of 12-13%, projected to rise to 15-16%.